INCIDENCE AND MORTALITY RATES OF RECURRENT ISCHEMIC STROKES AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES IN THE UNITED STATES
Author(s)
Jinlin Song, PhD1, Emily Durden, PhD2, Manasvi Sundar, MPH1, Lawrence Fried, MBA, MD2, Jean Lee, PharmD, MS2, Keith A. Betts, PhD1.
1Analysis Group, Inc., Los Angeles, CA, USA, 2Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA.
1Analysis Group, Inc., Los Angeles, CA, USA, 2Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ, USA.
OBJECTIVES: To assess the incidence of recurrent ischemic stroke (IS) and associated mortality rates among Medicare beneficiaries with non-cardioembolic ischemic stroke (NCIS) or transient ischemic attack (TIA).
METHODS: Adults ≥65 years of age with a primary diagnosis of NCIS or TIA during an inpatient stay or emergency room visit, and without prior history of stroke, were identified from Medicare fee-for-service data (January 2007-September 2024). Incidence rates of the index NCIS/TIA and each recurrent IS following the previous stroke were estimated within the population at risk, as were all-cause mortality rates following the index and each recurrent stroke. Kaplan-Meier analysis was used to estimate incidence and mortality at landmark time points.
RESULTS: A total of 1,291,897 patients with NCIS/TIA were included (mean ± standard deviation [SD] age 77.8 ± 8.0 years; 56.3% females), with 62.0% having NCIS and 38.0% having TIA at index. Incidence rates of index NCIS/TIA and second, third, fourth, and fifth IS were 0.3, 3.0, 6.7, 10.0, and 13.6 per 100 person-years (PYs), respectively. Rates of second stroke at 30 days, 90 days, 1 year, and 5 years were 2.6%, 3.8%, 6.1%, and 13.9%; third: 4.2%, 6.7%, 12.0%, and 25.6%; fourth: 5.0%, 8.5%, 16.6%, and 33.8%; fifth: 5.8%, 10.4%, 20.4%, and 40.0%. The 1-year all-cause mortality rate was 15.0% following the index NCIS/TIA, 27.4% following the second stroke, 32.8% following the third, 36.8% following the fourth, and 36.5% following the fifth. Compared with patients with TIA, those with NCIS had higher rates of second stroke (NCIS: 3.9 per 100 PYs; TIA: 2.0 per 100 PYs) and higher 1-year mortality following the index event (19.8% vs 7.2%); however, rates were similar for subsequent recurrent strokes.
CONCLUSIONS: The risk of recurrent IS and associated mortality increases progressively with each subsequent event, highlighting the need for effective secondary stroke prevention strategies.
METHODS: Adults ≥65 years of age with a primary diagnosis of NCIS or TIA during an inpatient stay or emergency room visit, and without prior history of stroke, were identified from Medicare fee-for-service data (January 2007-September 2024). Incidence rates of the index NCIS/TIA and each recurrent IS following the previous stroke were estimated within the population at risk, as were all-cause mortality rates following the index and each recurrent stroke. Kaplan-Meier analysis was used to estimate incidence and mortality at landmark time points.
RESULTS: A total of 1,291,897 patients with NCIS/TIA were included (mean ± standard deviation [SD] age 77.8 ± 8.0 years; 56.3% females), with 62.0% having NCIS and 38.0% having TIA at index. Incidence rates of index NCIS/TIA and second, third, fourth, and fifth IS were 0.3, 3.0, 6.7, 10.0, and 13.6 per 100 person-years (PYs), respectively. Rates of second stroke at 30 days, 90 days, 1 year, and 5 years were 2.6%, 3.8%, 6.1%, and 13.9%; third: 4.2%, 6.7%, 12.0%, and 25.6%; fourth: 5.0%, 8.5%, 16.6%, and 33.8%; fifth: 5.8%, 10.4%, 20.4%, and 40.0%. The 1-year all-cause mortality rate was 15.0% following the index NCIS/TIA, 27.4% following the second stroke, 32.8% following the third, 36.8% following the fourth, and 36.5% following the fifth. Compared with patients with TIA, those with NCIS had higher rates of second stroke (NCIS: 3.9 per 100 PYs; TIA: 2.0 per 100 PYs) and higher 1-year mortality following the index event (19.8% vs 7.2%); however, rates were similar for subsequent recurrent strokes.
CONCLUSIONS: The risk of recurrent IS and associated mortality increases progressively with each subsequent event, highlighting the need for effective secondary stroke prevention strategies.
Conference/Value in Health Info
2026-05, ISPOR 2026, Philadelphia, PA, USA
Value in Health, Volume 29, Issue S6
Code
CO125
Topic
Clinical Outcomes
Topic Subcategory
Clinical Outcomes Assessment, Relating Intermediate to Long-term Outcomes
Disease
SDC: Cardiovascular Disorders (including MI, Stroke, Circulatory)